Socio-economic factors, mood, primary care utilization, and quality of life as predictors of intervention cessation and chronic stress in a type 2 diabetes prevention intervention (PREVIEW Study).
Adherence
Diabetes Mellitus
Drop out
Health Behaviors
Lifestyle
Overweight
Prevention
Quality of Life
Stress
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
30 08 2023
30 08 2023
Historique:
received:
24
04
2023
accepted:
20
08
2023
medline:
1
9
2023
pubmed:
31
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
Sedentary lifestyle and unhealthy diet combined with overweight are risk factors for type 2 diabetes (T2D). Lifestyle interventions with weight-loss are effective in T2D-prevention, but unsuccessful completion and chronic stress may hinder efficacy. Determinants of chronic stress and premature cessation at the start of the 3-year PREVIEW study were examined. Baseline Quality of Life (QoL), social support, primary care utilization, and mood were examined as predictors of intervention cessation and chronic stress for participants aged 25 to 70 with prediabetes (n = 2,220). Moderating effects of sex and socio-economic status (SES) and independence of predictor variables of BMI were tested. Participants with children, women, and higher SES quitted intervention earlier than those without children, lower SES, and men. Lower QoL, lack of family support, and primary care utilization were associated with cessation. Lower QoL and higher mood disturbances were associated with chronic stress. Predictor variables were independent (p ≤ .001) from BMI, but moderated by sex and SES. Policy-based strategy in public health should consider how preventive interventions may better accommodate different individual states and life situations, which could influence intervention completion. Intervention designs should enable in-built flexibility in delivery enabling response to individual needs. ClinicalTrials.gov Identifier: NCT01777893.
Sections du résumé
BACKGROUND
Sedentary lifestyle and unhealthy diet combined with overweight are risk factors for type 2 diabetes (T2D). Lifestyle interventions with weight-loss are effective in T2D-prevention, but unsuccessful completion and chronic stress may hinder efficacy. Determinants of chronic stress and premature cessation at the start of the 3-year PREVIEW study were examined.
METHODS
Baseline Quality of Life (QoL), social support, primary care utilization, and mood were examined as predictors of intervention cessation and chronic stress for participants aged 25 to 70 with prediabetes (n = 2,220). Moderating effects of sex and socio-economic status (SES) and independence of predictor variables of BMI were tested.
RESULTS
Participants with children, women, and higher SES quitted intervention earlier than those without children, lower SES, and men. Lower QoL, lack of family support, and primary care utilization were associated with cessation. Lower QoL and higher mood disturbances were associated with chronic stress. Predictor variables were independent (p ≤ .001) from BMI, but moderated by sex and SES.
CONCLUSIONS
Policy-based strategy in public health should consider how preventive interventions may better accommodate different individual states and life situations, which could influence intervention completion. Intervention designs should enable in-built flexibility in delivery enabling response to individual needs.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT01777893.
Identifiants
pubmed: 37649005
doi: 10.1186/s12889-023-16569-9
pii: 10.1186/s12889-023-16569-9
pmc: PMC10466828
doi:
Banques de données
ClinicalTrials.gov
['NCT01777893']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1666Subventions
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Prev Med Rep. 2018 Feb 02;9:131-137
pubmed: 29616185
Diabetes Res Clin Pract. 2011 Feb;91(2):141-7
pubmed: 21194779
J Diabetes Metab Disord. 2022 Aug 5;21(2):1519-1529
pubmed: 36404827
Obes Rev. 2018 Jan;19(1):81-97
pubmed: 28849612
Eat Weight Disord. 2008 Mar;13(1):30-7
pubmed: 18319635
PLoS Med. 2016 Jul 26;13(7):e1002097
pubmed: 27458730
BMC Public Health. 2013 Sep 11;13:828
pubmed: 24020677
J Epidemiol Community Health. 2016 Jun;70(6):596-601
pubmed: 26681293
BMC Health Serv Res. 2008 Sep 19;8:187
pubmed: 18803845
J Behav Med. 2021 Dec;44(6):853-859
pubmed: 34160724
Front Psychol. 2016 Aug 10;7:1136
pubmed: 27559319
World J Diabetes. 2017 Apr 15;8(4):120-129
pubmed: 28465788
Internet J Ment Health. 2009;6(1):
pubmed: 22303186
Eat Behav. 2016 Jan;20:27-33
pubmed: 26609668
Public Health Nurs. 2020 May;37(3):393-404
pubmed: 32160348
Prev Med. 1987 Nov;16(6):825-36
pubmed: 3432232
Diabetes Care. 2021 Jul;44(7):1491-1498
pubmed: 34088702
Eur J Clin Nutr. 2011 Oct;65(10):1141-7
pubmed: 21587283
Diabetes Obes Metab. 2021 Feb;23(2):324-337
pubmed: 33026154
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Diabetes Care. 2011 Jan;34 Suppl 1:S11-61
pubmed: 21193625
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Patient Educ Couns. 2005 Oct;59(1):1-12
pubmed: 16198213
Qual Life Res. 2016 Aug;25(8):1903-12
pubmed: 26896960
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
MMWR Morb Mortal Wkly Rep. 2017 Dec 22;66(50):1369-1373
pubmed: 29267260
Front Endocrinol (Lausanne). 2018 May 04;9:220
pubmed: 29780358
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Int J Behav Nutr Phys Act. 2015 Nov 26;12:146
pubmed: 26612691
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Clin Obes. 2017 Jun;7(3):123-135
pubmed: 28296261
Curr Diab Rep. 2012 Dec;12(6):769-81
pubmed: 22949135
Qual Life Res. 2004 Mar;13(2):299-310
pubmed: 15085902
J Diabetes Res. 2016;2016:2159890
pubmed: 26885527
PLoS Med. 2011 Feb;8(2):e1000419
pubmed: 21364974
Nutrients. 2017 Jun 20;9(6):
pubmed: 28632180
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33431602
Am J Mens Health. 2016 Nov;10(6):NP145-NP154
pubmed: 26130731
SSM Popul Health. 2020 May 11;11:100596
pubmed: 32462074
Medicine (Baltimore). 2018 Feb;97(5):e9790
pubmed: 29384876
Health Psychol. 2009 Jan;28(1):131-5
pubmed: 19210027
Nutrients. 2019 Feb 26;11(3):
pubmed: 30813612
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Diabetes Res Clin Pract. 2014 Feb;103(2):206-17
pubmed: 24300019
JMIR Form Res. 2022 Nov 25;6(11):e30285
pubmed: 36427239
Healthcare (Basel). 2023 Mar 03;11(5):
pubmed: 36900754
BMC Public Health. 2020 Feb 25;20(1):249
pubmed: 32093707
Nutrition. 2007 Nov-Dec;23(11-12):887-94
pubmed: 17869482
Health Educ Behav. 2018 Dec;45(6):997-1007
pubmed: 29478353
Health Qual Life Outcomes. 2018 Sep 19;16(1):189
pubmed: 30231882
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33441418
PLoS Med. 2013;10(7):e1001479
pubmed: 23843750
J Fam Pract. 2022 Jan;71(Suppl 1 Lifestyle):S24-S29
pubmed: 35389840
Obes Rev. 2019 Feb;20(2):171-211
pubmed: 30324651
Trends Endocrinol Metab. 2010 Mar;21(3):159-65
pubmed: 19926299
Diabetes Care. 2012 Apr;35(4):699-705
pubmed: 22338102
Horm Metab Res. 2010 Apr;42 Suppl 1:S37-55
pubmed: 20391307
Front Nutr. 2021 Nov 02;8:707682
pubmed: 34796192